Progress in drug delivery system for fibrosis therapy

Area of Science:

• Biomedical Engineering
• Pharmacology
• Pathology

Background:

• Fibrosis is a critical pathological process in chronic diseases, potentially leading to cirrhosis and cancer.
• Early intervention in fibrosis is vital for disease management and improving patient outcomes.
• Reversing fibrosis is a significant research focus, driving innovation in therapeutic strategies.

Purpose of the Study:

• To review current anti-fibrosis drug delivery systems.
• To elucidate the pathological mechanisms underlying liver, pulmonary, and renal fibrosis.
• To provide insights for future fibrosis drug and delivery system development.

Main Methods:

• Literature review of anti-fibrosis drug delivery systems.
• Analysis of pathological mechanisms in major organ fibrotic diseases.
• Synthesis of existing research for future applications.

Main Results:

• Significant progress has been made in developing effective anti-fibrosis drugs and targeted delivery systems.
• Existing research provides a foundation for next-generation delivery systems.
• Understanding pathological mechanisms is key to designing targeted therapies.

Conclusions:

• Advanced drug delivery systems are essential for effective anti-fibrosis treatments.
• This review consolidates knowledge on fibrosis mechanisms and delivery systems.
• Future research should focus on innovative delivery platforms for fibrosis reversal.